Clinical trial
Bone Marrow Stem Cell Infusion Following a Heart Attack
NCT00268307 · Minneapolis Heart Institute Foundation, Other · Completed
Key facts
| NCT number | NCT00268307 |
|---|---|
| Title | Bone Marrow Stem Cell Infusion Following a Heart Attack |
| Official title | Cellular Transplantation of Autologous Bone Marrow-Derived Stem Cells Following Myocardial Infarction |
| Lead sponsor | Minneapolis Heart Institute Foundation, Other |
| Collaborators | Allina Health System |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Acute Myocardial Infarction |
| Intervention type | Drug |
| Interventions | Autologous, Unfractionated Bone Marrow Mononuclear Cells |
| Enrollment | 41 |
| Start date | Dec 1, 2005 |
| Primary completion | Jan 1, 2010 |
| Completion | Sep 1, 2010 |
| First posted | Dec 22, 2005 |
| Last update posted | Dec 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: